Mainstream

Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook

Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook

Post ContentpsnlRead More

You might also be interested in reading Bitcoin ETFs bleed cash as Abu Dhabi doubles down.

August 6, 2025
In Mainstream